Grant: Project Grant
McGill University
$669,375.00
Chromatin-Binding Factor MYSM1 in B Lymphocyte Development
FY 2016-17
Summary
B cells are the key component of our immune system, and are responsible for antibody production in response to infections. B cells are continuously produced in our bone marrow throughout life from a small population of hematopoietic stem cells. Disruptions in B cell development can lead to life-threatening disorders including immunodeficiencies and leukemias. Recently we and others identified MYSM1 as an essential protein for normal B cell production in both mice and humans. MYSM1 is a DNA binding protein that regulates gene activity during the process of B cell differentiation from stem cells. In this work we propose to identify the genes regulated by MYSM1 and characterize the mechanisms of MYSM1 activity during B cell differentiation. The role of MYSM1 in B cell cancers, including leukemias and lymphomas, will also be addressed, using mouse as a model. The work is expected to advance our understanding of B cells, and the biology of the bone marrow and the immune system. In the long-term this may lead to a better understanding and management of diseases involving B cell dysfunction.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
356802
Name
Nijnik Anastasia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Chromatin-Binding Factor MYSM1 in B Lymphocyte Development
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$669,375
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
B Cells; Chromatin; Hematopoiesis; Lymphocyte Development; Transcriptional Regulation; Transgenic Mouse Models
Abstract
B cells are the key component of our immune system, and are responsible for antibody production in response to infections. B cells are continuously produced in our bone marrow throughout life from a small population of hematopoietic stem cells. Disruptions in B cell development can lead to life-threatening disorders including immunodeficiencies and leukemias. Recently we and others identified MYSM1 as an essential protein for normal B cell production in both mice and humans. MYSM1 is a DNA binding protein that regulates gene activity during the process of B cell differentiation from stem cells. In this work we propose to identify the genes regulated by MYSM1 and characterize the mechanisms of MYSM1 activity during B cell differentiation. The role of MYSM1 in B cell cancers, including leukemias and lymphomas, will also be addressed, using mouse as a model. The work is expected to advance our understanding of B cells, and the biology of the bone marrow and the immune system. In the long-term this may lead to a better understanding and management of diseases involving B cell dysfunction.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Nijnik, Anastasia
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $669,375~ $0~